ADR Biomedical Holdings (TSE:3750) Treasury Stock: 円-1.64 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3750 ADR Biomedical Holdings Inc TSE:3750
28 GF Score
Price 円792.00
GF Value 円39.51
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is ADR Biomedical Holdings Treasury Stock?

ADR Biomedical Holdings TSE:3750 28 Treasury Stock is 円-1.64 Mil as of Mar. 2026. GuruFocus rates TSE:3750 with a GF Score™ of 28/100 and a GF Value™ of 円39.51 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. ADR Biomedical Holdings's treasury stock for the quarter that ended in Mar. 2026 was 円-1.64 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

ADR Biomedical Holdings Treasury Stock Historical Data

* Premium members only.

The historical data trend for ADR Biomedical Holdings's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADR Biomedical Holdings Treasury Stock Chart

ADR Biomedical Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.98 -1.24 -1.49 -1.53 -1.64

ADR Biomedical Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.53 -1.53 -1.55 -1.59 -1.64
TSE:3750
28GF Score
ADR Biomedical Holdings Inc TSE:3750
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ADR Biomedical Holdings Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of 円-1.64 Mil mean?
ADR Biomedical Holdings (TSE:3750) has a Treasury Stock of 円-1.64 Mil as of Mar. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for ADR Biomedical Holdings and its competitors.
Is ADR Biomedical Holdings' Treasury Stock too high?
ADR Biomedical Holdings' current Treasury Stock is 円-1.64 Mil. Overall, ADR Biomedical Holdings has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ADR Biomedical Holdings' Treasury Stock compare to VRTX and REGN?
ADR Biomedical Holdings' Treasury Stock of 円-1.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Biotechnology company?
A good Treasury Stock depends on the Biotechnology industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for ADR Biomedical Holdings and its competitors. ADR Biomedical Holdings's current Treasury Stock is 円-1.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADR Biomedical Holdings stock overvalued right now?
Based on GuruFocus' analysis, ADR Biomedical Holdings (TSE:3750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.51, compared to a current price of 円792.00 — trading 1904.6% above its estimated fair value. The current Treasury Stock is 円-1.64 Mil. ADR Biomedical Holdings' overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For ADR Biomedical Holdings (TSE:3750), the current Treasury Stock is 円-1.64 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ADR Biomedical Holdings (TSE:3750) Overvalued in 2026?

Based on GuruFocus' analysis, ADR Biomedical Holdings stock appears to be overvalued. The current stock price of 円792.00 is trading 1904.6% above its estimated GF Value™ of 円39.51. GuruFocus considers ADR Biomedical Holdings to be Significantly Overvalued.

Key valuation signals for TSE:3750:

  • Treasury Stock: 円-1.64 Mil
  • GF Value™: 円39.51 vs. price of 円792.00 (1904.6% above fair value)
  • GF Score™: 28/100 with 8 warning signs

No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ADR Biomedical Holdings Business Description

Address 1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
28GF Score

Get the complete analysis for TSE:3750

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円792.00
Price
円39.51
GF Value